Catherine Schulte
Stock Analyst at Baird
(1.5)
# 1641
Out of 5,368 analysts
140
Total ratings
51.40%
Success rate
6.68%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
A Agilent Technologies | Maintains: Outperform | 159 140 | 117.06 | 19.6% | 16 | May 22, 2025 | |
MRVI Maravai LifeSciences | Maintains: Neutral | 3 2 | 2.14 | -6.54% | 6 | May 13, 2025 | |
EXAS Exact Sciences | Maintains: Outperform | 69 72 | 53.52 | 34.53% | 14 | May 2, 2025 | |
AVTR Avantor | Maintains: Outperform | 21 17 | 13.07 | 30.07% | 11 | Apr 28, 2025 | |
TMO Thermo Fisher Scient... | Maintains: Outperform | 603 573 | 402.51 | 42.36% | 26 | Apr 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 231 225 | 200.65 | 12.14% | 9 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1369 1034 | 1155.16 | -10.49% | 8 | Apr 22, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 42 43 | 47.08 | -8.67% | 4 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 88 68 | 50.53 | 34.57% | 9 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 182 165 | n/a | n/a | 6 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 38 | 18.77 | 102.45% | 7 | Mar 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 56 33 | 33.55 | -1.64% | 3 | Nov 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | n/a | n/a | 1 | Jun 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 335 281 | 86.96 | 223.14% | 6 | Sep 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 21 | n/a | n/a | 1 | May 26, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 29 | n/a | n/a | 5 | Apr 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 208 217 | 342.12 | -36.57% | 7 | Oct 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 20 | 165.33 | -87.9% | 1 | Jun 28, 2018 |